Literature DB >> 17115116

Effects of resveratrol in inflammatory arthritis.

N Elmali1, O Baysal, A Harma, I Esenkaya, B Mizrak.   

Abstract

UNLABELLED: Nuclear factor kappa B (NF-kappaB), is a pivotal transcription factor involved in the activation of the TNF-alpha and IL-1beta genes. Activation of NF-kappaB in synovial cells is a feature seen in arthritis patients. Resveratrol, a polyphenolic, natural phytoalexin found with particularly high levels in grape skin and red wine is potent and specific inhibitor of TNF-alpha and IL-1beta induced NF-kappaB activation. We aimed to determine the in vivo effects of intra-articular injections of resveratrol on cartilage and synovium in an experimental rabbit inflammatory arthritis model.
MATERIALS AND METHODS: Arthritis was induced by intra-articular injection of three times of 50 mug lipopolysaccharide (LPS) at day 0, 4 and 8 at 4-day intervals into the knee joints of rabbits. To the test group, 10 muMol/kg resveratrol in the DMSO was injected in the knees at day 0 and then it was continued once daily for 2 weeks. To the control group the same time and amount of DMSO was injected the knees of rabbits. All rabbits were killed 1 week after the last injection and cartilage tissue and synovium were evaluated with semiquantitative scoring histologically.
RESULTS: According to control group in the resveratrol group, significantly decreased cartilage destruction was determined by H&E staining (p = 0.04). Loss of matrix proteoglycan content in the cartilage was much lower, as determined by safranin O staining (p = 0.03). We also observed marked synovial inflammation after intra-articular injection to control knees, but not in the resveratrol treated group knees (p = 0.01).
CONCLUSION: This study suggests that intra-articular injection of resveratrol may protect cartilage against the development of experimentally induced IA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17115116     DOI: 10.1007/s10753-006-9012-0

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

1.  Plasma and tissue resveratrol concentrations and pharmacological activity.

Authors:  A Bertelli; A A Bertelli; A Gozzini; L Giovannini
Journal:  Drugs Exp Clin Res       Date:  1998

2.  Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis.

Authors:  C Plater-Zyberk; L A Joosten; M M Helsen; P Sattonnet-Roche; C Siegfried; S Alouani; F A van De Loo; P Graber; S Aloni; R Cirillo; E Lubberts; C A Dinarello; W B van Den Berg; Y Chvatchko
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 3.  Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation.

Authors:  Y J Surh; K S Chun; H H Cha; S S Han; Y S Keum; K K Park; S S Lee
Journal:  Mutat Res       Date:  2001-09-01       Impact factor: 2.433

4.  A monoarthritis model in rabbits induced by repeated intra-articular injections of lipopolysaccharide.

Authors:  H Idogawa; A Imamura; K Matsuo; K Yoshitake; T Umemura; M Ohashi
Journal:  Int J Exp Pathol       Date:  1998-04       Impact factor: 1.925

Review 5.  Signal transduction in rheumatoid arthritis.

Authors:  Susan E Sweeney; Gary S Firestein
Journal:  Curr Opin Rheumatol       Date:  2004-05       Impact factor: 5.006

Review 6.  Apoptosis as a therapeutic tool in rheumatoid arthritis.

Authors:  Richard M Pope
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

7.  Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.

Authors:  J Bondeson; B Foxwell; F Brennan; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

8.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

9.  Interleukin 6 is required for the development of collagen-induced arthritis.

Authors:  T Alonzi; E Fattori; D Lazzaro; P Costa; L Probert; G Kollias; F De Benedetti; V Poli; G Ciliberto
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

10.  Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Authors:  L A Joosten; E Lubberts; M M Helsen; T Saxne; C J Coenen-de Roo ; D Heinegård; W B van den Berg
Journal:  Arthritis Res       Date:  1999-10-26
View more
  71 in total

1.  Overexpression of SIRT1 Induced by Resveratrol and Inhibitor of miR-204 Suppresses Activation and Proliferation of Microglia.

Authors:  Lihong Li; Qiang Sun; Yuqian Li; Yang Yang; Yanlong Yang; Tao Chang; Minghao Man; Longlong Zheng
Journal:  J Mol Neurosci       Date:  2015-03-01       Impact factor: 3.444

Review 2.  Dietary factors in rheumatic autoimmune diseases: a recipe for therapy?

Authors:  Shani Dahan; Yahel Segal; Yehuda Shoenfeld
Journal:  Nat Rev Rheumatol       Date:  2017-04-13       Impact factor: 20.543

Review 3.  A current review of molecular mechanisms regarding osteoarthritis and pain.

Authors:  Andrew S Lee; Michael B Ellman; Dongyao Yan; Jeffrey S Kroin; Brian J Cole; Andre J van Wijnen; Hee-Jeong Im
Journal:  Gene       Date:  2013-07-02       Impact factor: 3.688

Review 4.  Modulation of Inflammatory Response to Implanted Biomaterials Using Natural Compounds.

Authors:  Maria Yanez; James Blanchette; Ehsan Jabbarzadeh
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

5.  Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway.

Authors:  Jing Tian; Jin-wei Chen; Jie-sheng Gao; Len Li; Xi Xie
Journal:  Rheumatol Int       Date:  2013-01-18       Impact factor: 2.631

6.  The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3.

Authors:  Z Li; B Bridges; J Olson; S A Weinman
Journal:  Oncogene       Date:  2016-09-26       Impact factor: 9.867

Review 7.  Small molecule SIRT1 activators for the treatment of aging and age-related diseases.

Authors:  Basil P Hubbard; David A Sinclair
Journal:  Trends Pharmacol Sci       Date:  2014-01-16       Impact factor: 14.819

8.  Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation.

Authors:  Stefan Bereswill; Melba Muñoz; André Fischer; Rita Plickert; Lea-Maxie Haag; Bettina Otto; Anja A Kühl; Christoph Loddenkemper; Ulf B Göbel; Markus M Heimesaat
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

Review 9.  Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

10.  Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells.

Authors:  Constanze Buhrmann; Franziska Busch; Parviz Shayan; Mehdi Shakibaei
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.